Clinical Trial Update: A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion of a Phase I/IIa clinical trial of the UV1 vaccine in men with prostate cancer. The trial was sponsored by Ultimovacs ASA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• UV1 vaccine (UV1 vaccine)

Snippet

Sponsor: Ultimovacs ASA | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED